Related Experiment Video

Updated: Oct 13, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Mechanism of differential effects of antihypertensive agents on serum lipids

R D Brook1

  • 1Division of Hypertension, 3918 Taubman Center, University of Michigan, 1500 E. Medical Center Drive, Ann Arbor, MI 48104, USA. robdbrok@groupwise.umich.edu.

Current Hypertension Reports
|September 12, 2000
PubMed

Insights

Essential hypertension often includes metabolic issues like insulin resistance. Alpha-blockers improve insulin sensitivity and lipids, unlike other blood pressure drugs.

Area of Science:

  • Cardiology
  • Endocrinology
  • Pharmacology

Background:

  • Essential hypertension frequently coexists with metabolic syndrome components, including insulin resistance and dyslipidemia.
  • This clustering of cardiovascular risk factors may limit benefits from blood pressure reduction alone.
  • Many antihypertensive drugs do not improve, or may worsen, associated metabolic abnormalities.

Purpose of the Study:

  • To review the metabolic effects of various antihypertensive medication classes.
  • To highlight the impact of these drugs on insulin sensitivity, dyslipidemia, and postprandial lipid metabolism.
  • To discuss the implications for endothelial function and cardiovascular risk.

Main Methods:

  • Literature review of studies on antihypertensive medications and metabolic parameters.
  • Analysis of physiological mechanisms affecting plasma lipids.
  • Examination of effects on glucose tolerance and lipid profiles.

Main Results:

  • Beta-blockers and diuretics generally worsen glucose tolerance and plasma lipids.
  • Calcium channel blockers, ACE inhibitors, and ARBs are typically metabolically neutral.
  • Alpha-blockers demonstrate favorable metabolic effects, improving insulin sensitivity and dyslipidemia.

Conclusions:

  • Antihypertensive drug choice significantly impacts metabolic health.
  • Alpha-blockers offer unique metabolic benefits compared to other classes.
  • Further attention to postprandial lipid metabolism and endothelial dysfunction is warranted.

Related Concept Videos

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...